Viberzi 75 mg

VIBERZI 75 MG tablets contain eluxadoline, a medication used to manage irritable bowel syndrome with diarrhea (IBS-D). This oral treatment is designed to help alleviate symptoms and improve quality of life for those affected by IBS-D.

VIBERZI 75 MG is primarily used for the management of irritable bowel syndrome with diarrhea (IBS-D). This medication works by targeting receptors in the gut to reduce symptoms such as abdominal pain, diarrhea, and urgency. It is specifically formulated for adults experiencing these symptoms, providing a targeted approach to symptom relief.

Common effects of VIBERZI 75 MG may include constipation, nausea, and abdominal pain. Some users may also experience fatigue or dizziness. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

VIBERZI 75 MG should be handled with care, especially for individuals with a history of pancreatitis, severe liver impairment, or alcoholism. It is crucial to follow the prescribed guidelines and consult a healthcare provider before starting this medication. Always store the tablets in a cool, dry place away from direct sunlight.

VIBERZI 75 MG may interact with certain medications, including strong CYP2C9 inhibitors and alcohol. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication to prevent adverse effects.